SGRY

Surgery Partners, Inc.

Healthcare · $1.9B market cap

Verdict

Share price

$13.32

close of Oct 3, 2026

Fair value

$30.56

Sticker Price

Payback Price

$12.23

buy price

Undervalued

SGRY is Undervalued: at $13.32 it trades 56% below its fair value of $30.56. Its buy price (Payback Price) is $12.23, 8% below today's price. Business quality is mixed: 2 of 5 key numbers clear the 10% bar.

How we valued it

Free Cash Flow Growth. There's too little earnings history to value it on earnings, but it has produced free cash flow consistently, so we value it on cash flow.

Business quality

2 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth—?
Equity per share growth2.7% a year✗
Sales growth14.1% a year✓
Free cash flow growth12.6% a year✓
Return on invested capital3.2%✗

Follow SGRY

Get notified when it reaches its buy price of $12.23. Free.

Create a free account

Superinvestors

1 of the investors we track holds SGRY. In Q2 2026, 1 opened a position. Who we track

Moves in Q2 2026

New position: Howard Marks

Insider activity

Since Jun 18, 2026: 2 open-market purchases worth $305K and 1 other filing (stock awards, tax withholding and similar). Why purchases matter

Purchases

Other filings

About Surgery Partners, Inc.

Surgery Partners, Inc. operates a nationwide network of surgical facilities and associated medical services across the United States. Its business is categorized into two segments: Surgical Facility Services and Ancillary Services. These surgical venues include both ambulatory surgery centers and dedicated surgical hospitals, delivering non-urgent surgical procedures across various specialties such as…

Medical - Care Facilities

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works